Outset Medical Operating Cash Flow Per Share 2019-2025 | OM
Outset Medical operating cash flow per share from 2019 to 2025. Operating cash flow per share can be defined as a measure of financial performance calculated as operating cash flow, expressed on a per share basis
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.366B | $0.114B |
| Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.227B | 59.07 |
| Hims & Hers Health (HIMS) | United States | $12.367B | 128.49 |
| Tempus AI (TEM) | United States | $12.011B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.742B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.033B | 63.01 |
| Hinge Health (HNGE) | United States | $2.855B | 0.00 |
| Privia Health (PRVA) | United States | $2.804B | 191.67 |
| Schrodinger (SDGR) | United States | $1.917B | 0.00 |
| Enovis (ENOV) | United States | $1.916B | 10.69 |
| Phreesia (PHR) | United States | $1.667B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.522B | 0.00 |
| Omnicell (OMCL) | United States | $1.463B | 25.82 |
| Azenta (AZTA) | United States | $1.393B | 64.72 |
| 10x Genomics (TXG) | United States | $1.311B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.663B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.645B | 0.00 |
| Claritev (CTEV) | United States | $0.631B | 0.00 |
| Talkspace (TALK) | United States | $0.499B | 149.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 824.33 |
| Health Catalyst (HCAT) | United States | $0.288B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.137B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 3.60 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.030B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |